Premium
Premium statistics

Industry-specific and extensively researched technical data (partially from exclusive partnerships).

A paid subscription is required for full access.

Top 10 therapeutic classes by estimated global pharmaceutical sales in 2017 (in billion U.S. dollars)

Exclusive Premium Statistic

Top therapeutic classes by global pharmaceutical sales 2017 estimates This statistic depicts the top 10 therapeutic classes by global pharmaceutical sales in 2017. In that year, the global pharmaceutical industry is estimated to generate a total revenue of some 36 billion U.S. dollars through mental health drug spending.
Top therapeutic classes and drugs

Oncologics, pain therapy, and anti-diabetics are among the top global pharmaceuticals based on revenues, generating 81 billion U.S. dollars, 76 billion U.S. dollars, and 72 billion U.S. dollars, respectively, in 2017. In oncologic developments, drugs for non-small cell lung cancer and breast cancer were among the leading diseases in therapeutic drug development. On the other hand, mental health drugs like Cymbalta generated over 36 billion dollars of revenue worldwide. Cymbalta is manufactured by Eli Lilly and used to treat major depressive disorder and generalized anxiety disorder.

One of Bristol-Myers Squibb’s most profitable medications was Abilify, a neurology product that generated revenue of 5.8 billion U.S. dollars in the United States in 2015. Aripiprazole, marketed as Abilify, is used for the treatment of schizophrenia, bipolar disorder, and major depressive disorder, among other disorders. Bristol-Myers Squibb’s neuroscience program focuses on the development of therapeutic regimens for disorders that impact the brain and nervous systems. Some of the company’s other therapeutic areas of focus include cardiovascular, immunoscience, and virology.
Show more
Sales in billion U.S. dollars
--
--
--
--
--
--
--
--
--
--
Sales in billion U.S. dollars
--
--
--
--
--
--
--
--
--
--

Exclusive Premium statistic

You need a Premium Account for unlimited access.

  • Full access to 1.5m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Premium Account


only $49 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$588 / Year

View price details

Exclusive Premium statistic

You need a Premium Account for unlimited access.

  • Full access to 1.5m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Premium Account


only $49 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$588 / Year

View price details

Download Settings Share
Chart type
Datalabels
Share on Social Media
Download started
Please be patient - this may take a moment
Description Source More information
This statistic depicts the top 10 therapeutic classes by global pharmaceutical sales in 2017. In that year, the global pharmaceutical industry is estimated to generate a total revenue of some 36 billion U.S. dollars through mental health drug spending.
Top therapeutic classes and drugs

Oncologics, pain therapy, and anti-diabetics are among the top global pharmaceuticals based on revenues, generating 81 billion U.S. dollars, 76 billion U.S. dollars, and 72 billion U.S. dollars, respectively, in 2017. In oncologic developments, drugs for non-small cell lung cancer and breast cancer were among the leading diseases in therapeutic drug development. On the other hand, mental health drugs like Cymbalta generated over 36 billion dollars of revenue worldwide. Cymbalta is manufactured by Eli Lilly and used to treat major depressive disorder and generalized anxiety disorder.

One of Bristol-Myers Squibb’s most profitable medications was Abilify, a neurology product that generated revenue of 5.8 billion U.S. dollars in the United States in 2015. Aripiprazole, marketed as Abilify, is used for the treatment of schizophrenia, bipolar disorder, and major depressive disorder, among other disorders. Bristol-Myers Squibb’s neuroscience program focuses on the development of therapeutic regimens for disorders that impact the brain and nervous systems. Some of the company’s other therapeutic areas of focus include cardiovascular, immunoscience, and virology.
Show more
Release date
March 2018
Region
Worldwide
Survey time period
as of October 2017
Supplementary notes
The statistic includes 8 developed and 6 pharmerging countries: U.S., EU5, Japan, Canada, China, Brazil Russia, India, Turkey, Mexico.

More information

Statista Accounts: Access All Statistics. Starting from $588 / Year

Basic Account

Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account

Your perfect start with Statista

  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$49 / Month *

Corporate Account

Full access

Corporate solution including all features.

Send request

* All products require an annual contract.
   Prices do not include sales tax
   (New York residents only).
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom

Related Studies: Available to Download in PDF or PPTX Format

Top pharmaceutical drugs
Top pharmaceutical drugs

All Information
in one Presentation

Top pharmaceutical drugs

Everything On "Top pharmaceutical drugs" in One Document: Edited and Divided into Handy Chapters. Including Detailed References.

Other Reports & Dossiers
Statista has been my savior on several occasions. The site is easy to maneuver and the data is in a format that can go right into a report or presentation.
Marlene Greenfield

Marlene Greenfield
Vice President, Hearst Magazines

Statistics on "Global pharmaceutical industry"

  • Overview
The most important statistics
  • Companies and products
  • Top companies by revenue
  • R&D, patents, new products
  • Outlook
Need help with using Statista for your research? Tutorials and first steps

Further Content: Statistics, Studies, and Topic Pages

Statistics on the topic

Topics

About Statista

Learn more about how Statista can support your business.

Request webinar
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.